Timely and relevant thoracic oncology news brought to you by the only global association dedicated to the multidisciplinary study of lung cancer.

Timely and relevant thoracic oncology news brought to you by the only global association dedicated to the multidisciplinary study of lung cancer.

Evolving Standards of Care

August 19, 2020

Expanding Efforts Help Address Disparities in Lung Cancer Care

By

Evolving Standards of Care

By Kara Nyberg, PhD Posted: August 19, 2020 A multitude of factors contribute to disparities in lung cancer care, including sex, race, education level, income, geographic region, and access to […]
August 14, 2020

Dr. Harpreet Singh Discusses the Conduct of FDA Clinical Trials During the COVID-19 Pandemic

By

Evolving Standards of Care

Harpreet Singh, MD, is director of Division of Oncology 2 at the U.S. Food and Drug Administration (FDA). In the following interview, she discusses the FDA’s response to the COVID-19 […]

June 24, 2020

Broad Molecular Testing in Lung Cancer: The Struggle to Translate Recommendations to Clinical Practice

By

Evolving Standards of Care

By Kara Nyberg, PhD Posted: June 24, 2020 Over the past decade, lung cancer has emerged as a shining example of how precision medicine can dramatically improve patient outcomes. Up […]
June 24, 2020

Evolution of Research Using Patient-Reported Outcomes in Lung Cancer: A Q&A With Dr. Benjamin Movsas

By

Evolving Standards of Care

Posted: June 24, 2020 The IASLC Lung Cancer News spoke with Benjamin Movsas, MD, regarding the evolution of patient-reported outcomes (PROs) for lung cancer. Dr. Movsas is the co-chair of […]
June 24, 2020

TTFields in Unresectable MPM: STELLAR Results in Practice

By

Evolving Standards of Care

By Giovanni Luca Ceresoli, MD Posted: June 24, 2020 Dr. Giovanni Luca Ceresoli Tumor-treating fields (TTFields) are a noninvasive, regional treatment based on the delivery of low-intensity alternating electric […]

June 23, 2020

Stage IIIA NSCLC: A Review of Recent and Ongoing Trials Trial

By

Evolving Standards of Care

By Mariano Provencio, MD, PhD Posted: June 24, 2020 Data can help inform change to standard of care, but at what point do we say enough data is enough and […]

June 23, 2020

TTFields in Mesothelioma (The STELLAR Trial): More Stars Needed in the Constellation

By

Evolving Standards of Care

By Paul Baas, MD, PhD, and Cornedine J. de Gooijer, MD Posted: June 24, 2020 Recently, a manuscript by Ceresoli et al. was published in The Lancet Oncology.1 The study […]
June 23, 2020

Multidisciplinary Tumor Boards: Approaches Across Different Institutions

By

Evolving Standards of Care

Posted: June 24, 2020 In an effort to provide its audience with information about best practices for multidisciplinary communication, ILCN will be highlighting the approaches of different international institutions. From […]
June 23, 2020

Multidisciplinary Tumor Board: A Single Institution’s Perspective

By

Evolving Standards of Care

By Ari Rosenberg, MD Posted: June 24, 2020 As 7:00 AM approaches, the ninth-floor conference room slowly fills as team members file in and find their seats. The senior […]
June 9, 2020

Losing the Personal Touch in the Digital World

By

Evolving Standards of Care

By Rebecca Matthias, MD Posted: June 10, 2020 Ms. Matthias is a patient with lung cancer who, along with so many, has transitioned to telehealth. Ms. Matthias lives in […]